Skip to content
DeepViews

UFP Technologies Inc (UFPT) — Analysis Summary

UFP Technologies Inc (UFPT) has a market cap of $2.29B with year-over-year revenue growth of +19.5%. Net margin stands at 11.3%. The stock trades at a P/E ratio of 31.7.

Key Takeaways

  • Revenue changed +19.5% year-over-year
  • Net margin of 11.3%
  • P/E ratio of 31.7

Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, UFPT posted revenue growth of +19.5% and trades at a P/E of 31.7.

[XNAS]

UFP Technologies Inc (UFPT)

$295.82

PREVIOUS CLOSE 2026-10-12 · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$2291.36M
Enterprise Value
$2399.62M
P/E Ratio
31.7
Div Yield
0.00%
EV/EBITDA
21.6
Company Profile
About
About UFP Technologies Inc

UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Sector

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Employees

5,349

Headquarters

NEWBURYPORT, MA

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
69
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$462.43M
Total Debt$117.31M
Debt-to-Equity0.25
Cash & Equivalents$9.04M

Cash Flow

Operating Cash Flow$71.58M
Free Cash Flow$0.00M
FCF Margin0.00%
P/FCF RatioN/A
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.